Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Xenotropic and polytropic retrovirus receptor 1 (XPR1) is a membrane transporter and the only known inorganic phosphate exporter in mammals, belonging to the solute carrier family 53 (SLC53A1)[1][3]. It has a dimeric structure with 10 transmembrane domains and a key cytoplasmic SPX domain involved in phosphate sensing and regulation[2][3]. XPR1 plays a central role in maintaining intracellular and systemic phosphate balance by exporting phosphate out of cells. It also serves as the cellular receptor for xenotropic and polytropic murine leukemia viruses, mediating their entry[1]. Pathogenic mutations in XPR1 can impair phosphate export, leading to diseases such as primary familial brain calcification (PFBC) characterized by ectopic brain calcifications and neurological symptoms[1][2]. There are currently no approved drugs targeting XPR1’s phosphate transport or viral receptor functions[2][3].
Not applicable (no marketed drugs; potential future mechanisms may involve modulation or inhibition of phosphate export or viral entry[2][3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Xenotropic and polytropic retrovirus receptor 1 (XPR1).